Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancer (Q73181849)
Jump to navigation
Jump to search
scientific article published on 01 September 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancer |
scientific article published on 01 September 1999 |
Statements
Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancer (English)
M Ducreux
J F Seitz
M Bonnay
A Bexon
J P Armand
M Mahjoubi
D Méry-Mignard
1 September 1999